Burleson & Company, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Burleson & Company, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,449
-38.8%
7800.0%0.00%0.0%
Q3 2022$4,000
+33.3%
7800.0%0.00%0.0%
Q2 2022$3,000
-40.0%
7800.0%0.00%0.0%
Q1 2022$5,000
-16.7%
7800.0%0.00%0.0%
Q4 2021$6,000
-14.3%
7800.0%0.00%0.0%
Q3 2021$7,000
-22.2%
7800.0%0.00%0.0%
Q2 2021$9,000
-10.0%
7800.0%0.00%
-50.0%
Q1 2021$10,0007800.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders